Anbio Biotechnology Class A (NNNN) Price & Analysis
NNNN Stock Chart & Stats
- Day’s Range
- $3.33 - $3.75
- 52-Week Range
- $3.09 - $44.73
- Previous Close
- $3.72
- Volume
- 119.76K
- Average Volume (3M)
- 85.89K
- Market Cap
- $483.47M
- Enterprise Value
- $688.35T
- Total Cash (Recent Filing)
- $11.90M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- 17.4
- Beta
- 1.73
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
NNNN FAQ
What was Anbio Biotechnology Class A’s price range in the past 12 months?
What is Anbio Biotechnology Class A’s market cap?
When is Anbio Biotechnology Class A’s upcoming earnings report date?
Is Anbio Biotechnology Class A overvalued?
Does Anbio Biotechnology Class A pay dividends?
What is Anbio Biotechnology Class A’s EPS estimate?
How many shares outstanding does Anbio Biotechnology Class A have?
Which hedge fund is a major shareholder of Anbio Biotechnology Class A?
What is the TipRanks Smart Score and how is it calculated?
Anbio Biotechnology Class A Stock Smart Score
Company Description
Anbio Biotechnology Class A
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- Michael Lau
- Employees
- 27
- Website
- www.anbio.com
- Address
- Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, 60327, DE
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 5 | 15 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 0 | 0 | 12 |